Tri Chemical Laboratories Inc. (4369) AI Stock Analysis

• Market Cap: ¥96.74B
• Dividend Yield: 1.2%
• Average Volume (3M): 909.57K
• Price to Earnings (P/E): 16.9
• Beta (1Y): 1.10
• Revenue Growth: 71.39%
• EPS Growth: 87.22%
• Country: JP
• Employees: 274
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 48.29
• Shares Outstanding: 32,498,640
• 10 Day Avg. Volume: 605,360
• 30 Day Avg. Volume: 909,566
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥3,500.00
• Price Target Upside: 20.19% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 68 Neutral
• Price Target: ¥3,174.00 ▲(9.00% Upside)

Tri Chemical Laboratories Inc. has a solid financial foundation with strong revenue growth and profitability, but faces challenges in cash flow management. The technical indicators suggest a bearish trend, while the valuation is reasonable with a modest dividend yield. These factors combined result in a moderate overall stock score.

Tri Chemical Laboratories Inc. Business Overview & Revenue Model

Company Description

Tri Chemical Laboratories Inc. is a leading provider of specialty chemicals and chemical services, primarily serving the agriculture, industrial, and environmental sectors. The company focuses on developing innovative chemical solutions that enhance product performance and operational efficiency for its clients. Core offerings include custom chemical formulations, analytical testing services, and regulatory compliance assistance, aimed at facilitating a wide range of applications from crop protection to water treatment.

How the Company Makes Money

Tri Chemical Laboratories generates revenue through multiple streams, including the sale of specialty chemical products, analytical testing services, and consulting on regulatory compliance. The primary revenue comes from direct sales of its custom chemical formulations to agricultural businesses and industrial clients. Additionally, the company earns income from its laboratory services, which provide essential testing and analysis for clients in various sectors. Strategic partnerships with agricultural and industrial firms enhance its market reach, while ongoing investments in research and development allow Tri Chemical to innovate and introduce new products, further driving revenue growth.

Tri Chemical Laboratories Inc. Financial Statement Overview

Summary

Tri Chemical Laboratories Inc. demonstrates strong revenue growth and profitability with a solid balance sheet. However, cash flow challenges, particularly negative free cash flow, could pose risks if not addressed.

Income Statement

Tri Chemical Laboratories Inc. shows strong revenue growth with a 17.43% increase in TTM, indicating robust demand. The company maintains healthy profitability with a gross profit margin of 41.64% and a net profit margin of 24.13% in TTM. EBIT and EBITDA margins are also solid at 30.16% and 36.65%, respectively, reflecting efficient operations. However, slight declines in gross and net profit margins compared to previous periods suggest potential cost pressures.

Balance Sheet

The balance sheet is strong with a low debt-to-equity ratio of 0.0468, indicating low leverage and financial stability. Return on equity is healthy at 17.64%, showcasing effective use of equity to generate profits. The equity ratio stands at 80.71%, reflecting a solid equity base. However, the slight decrease in stockholders' equity over recent periods could be a point of concern.

Cash Flow

Operating cash flow remains positive, but the free cash flow is negative, indicating potential challenges in cash generation after capital expenditures. The operating cash flow to net income ratio is 0.36, suggesting moderate cash conversion efficiency. The negative free cash flow growth rate and free cash flow to net income ratio highlight potential liquidity concerns.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	22.20B	18.91B	11.25B	13.80B	11.57B	9.80B
Gross Profit	9.25B	8.01B	4.09B	5.58B	4.84B	4.38B
EBITDA	8.14B	6.63B	4.61B	7.42B	6.35B	5.17B
Net Income	5.36B	4.96B	2.47B	4.83B	4.10B	3.38B
Balance Sheet
Total Assets	38.80B	36.94B	31.86B	32.12B	28.29B	19.87B
Cash, Cash Equivalents and Short-Term Investments	7.99B	9.44B	10.50B	11.14B	8.03B	1.70B
Total Debt	1.47B	1.78B	2.40B	3.24B	4.28B	5.05B
Total Liabilities	7.49B	5.36B	4.29B	6.24B	6.97B	7.27B
Stockholders Equity	31.32B	31.59B	27.57B	25.88B	21.32B	12.60B
Cash Flow
Free Cash Flow	-1.10B	605.75M	1.19B	4.84B	2.71B	-872.24M
Operating Cash Flow	2.32B	3.68B	2.97B	6.39B	3.64B	2.09B
Investing Cash Flow	-3.48B	-3.12B	-1.78B	-1.56B	-932.88M	-2.96B
Financing Cash Flow	-1.96B	-1.62B	-1.86B	-1.70B	3.59B	948.34M

Tri Chemical Laboratories Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2912.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4369, the sentiment is Negative. The current price of 2912 is below the 20-day moving average (MA) of 2977.95, below the 50-day MA of 2949.26, and below the 200-day MA of 3009.24, indicating a bearish trend. The MACD of -0.06 indicates Positive momentum. The RSI at 48.64 is Neutral, neither overbought nor oversold. The STOCH value of 39.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4369.

Tri Chemical Laboratories Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4365	79 Outperform	¥63.10B	10.01	―	2.11%	-1.66%	-29.18%
4008	69 Neutral	¥66.22B	14.16	―	4.21%	0.32%	-43.10%
4113	69 Neutral	¥18.10B	11.13	―	3.17%	7.57%	35.66%
4369	68 Neutral	¥96.74B	16.95	―	1.20%	71.39%	87.22%
4028	67 Neutral	¥91.70B	8.55	―	4.98%	8.46%	74.58%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%

Tri Chemical Laboratories Inc. Corporate Events

Tri Chemical Laboratories Reports Strong Q1 2025 Financial Growth

Tri Chemical Laboratories Inc. reported significant financial growth for the three months ended April 30, 2025, with net sales doubling and operating profit increasing by 157.6% compared to the previous year. This financial performance indicates a strong market position and potential positive implications for stakeholders, as the company maintains a robust capital adequacy ratio of 80.7% and forecasts continued growth in the fiscal year ending January 31, 2026.

The most recent analyst rating on (JP:4369) stock is a Buy with a Yen5100.00 price target. To see the full list of analyst forecasts on Tri Chemical Laboratories Inc. stock, see the JP:4369 Stock Forecast page.

Tri Chemical Laboratories Explores Joint Ventures in China

Tri Chemical Laboratories Inc. has signed a memorandum of understanding with Hefei ADChem Semi-Tech. Co., Ltd. to explore joint ventures in the Chinese semiconductor market. This collaboration aims to leverage ADChem’s technological capabilities and market presence in China, though it is expected to have minimal impact on Tri Chemical’s performance in the current fiscal year.

The most recent analyst rating on (JP:4369) stock is a Buy with a Yen5100.00 price target. To see the full list of analyst forecasts on Tri Chemical Laboratories Inc. stock, see the JP:4369 Stock Forecast page.